Prof Tomas Kalincik
Professorial Fellow, Neurological Outcomes
Department of Medicine
646 Scholarly works
30 Projects
HIGHLIGHTS
2024
Research grants (ARC, NHMRC, MRFF)
New Paradigms in Prevention of Disability in Multiple Sclerosis
2021
Journal article
Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis
DOI: 10.1212/WNL.00000000000127532018
Research grants (ARC, NHMRC, MRFF)
Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Central Operating)
2018
Research Grant
Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Stream 1 & 2)
2015
Journal article
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
DOI: 10.1002/ana.243392014
Journal article
Fingolimod after natalizumab and the risk of short-term relapse
DOI: 10.1212/WNL.00000000000002832013
Journal article
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
DOI: 10.1093/brain/awt281
RECENT SCHOLARLY WORKS
2026
Journal article
Corrigendum to “Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study” [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885] (Multiple Sclerosis and Related Disorders (2026) 106, (S2211034825006236), (10.1016/j.msard.2025.106885))
DOI: 10.1016/j.msard.2026.1071312026
Journal article
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder
DOI: 10.1212/WNL.00000000002147072026
Journal article
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.
DOI: 10.1007/s40263-026-01287-82026
Journal article
Target trial emulation for causal inference using observational data in neurology.
DOI: 10.1016/j.neurol.2026.03.0012026
Journal article
Cross-sectional brain volumetric measures and disability outcomes in relapsing–remitting multiple sclerosis
DOI: 10.1007/s00415-026-13788-z2026
Journal article
Performance of the 2024 McDonald diagnostic criteria for multiple sclerosis
DOI: 10.1177/135245852614218162026
Journal article
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis
DOI: 10.1093/brain/awaf2862026
Journal article
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study
DOI: 10.1016/j.msard.2025.106885